Physician profile
Bridget Haslam
NPI 1619221959
$889.90
in general payments reported to CMS, 2019-2025
11 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $215 · 2023: $268 · 2024: $218 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $190.57 | 2022 | |
| Sanofi-Aventis U.S. LLC | $132.99 | 2024 | |
| Abbvie INC. | $121.02 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $116.70 | 2025 | Neffy |
| Amarin Pharma, INC. | $99.20 | 2023 | |
| Heron Therapeutics, INC. | $72.37 | 2022-2023 | Zynrelef |
| Abbott Laboratories | $50.39 | 2025 | Proclaim |
| Bioventus LLC | $45.29 | 2024 | Durolane |
| Si-Bone, INC. | $24.75 | 2024 | |
| Boston Scientific Corporation | $21.96 | 2025 | Wavewriter Alpha Prime 16 |
| Electronic Waveform Lab, INC. | $14.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Haslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.